Feds May End Hospital System’s Noncompete Contract for Part-Time DocsJuly 8, 2024Business of Medicine
Urticaria Linked to Higher Cancer Risk, Study FindsJuly 3, 2024Hodgkin LymphomaPatient & Survivor CareALLAggressive LymphomasAMLB Cell LymphomaCLL
Time Warp: Fax Machines Still Common in Oncology Practice. Why?July 3, 2024DLBCLGene TherapyMixed TopicsPediatricsAggressive LymphomasALLAML
Cancer Drug Shortages Continue in the US, Survey FindsJuly 3, 2024Aggressive LymphomasALLAMLB Cell LymphomaCLLCMLHodgkin Lymphoma
EMA Greenlights Four Drugs for Bladder and Other CancersJuly 2, 2024Patient & Survivor CareCMLNon-Hodgkin LymphomaB Cell Lymphoma
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching StudiesJune 28, 2024Business of MedicineMixed Topics
FDA Approves Epcoritamab for R/R Follicular LymphomaJune 27, 2024Indolent LymphomaPatient & Survivor Care
Neurofilament Light Chain Detects Early Chemotherapy-Related NeurotoxicityJune 26, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasAMLALL
